BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 11579649)

  • 1. A comparative trial of single dose chemotherapy in paucibacillary leprosy patients with two to three skin lesions.
    2-3 Lesion Multicentre Trial Group
    Indian J Lepr; 2001; 73(2):131-43. PubMed ID: 11579649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative clinico-pathological study of single dose ROM in paucibacillary leprosy patients with 1-3 skin lesions.
    Deshmukh AR; Dhurat RS; Jerajani HR
    Indian J Lepr; 2003; 75(3):209-17. PubMed ID: 15267190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of single dose multidrug therapy for the treatment of single-lesion paucibacillary leprosy. Single-lesion Multicentre Trial Group.
    Indian J Lepr; 1997; 69(2):121-9. PubMed ID: 9290963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of single-dose chemotherapy (rifampicin, ofloxacin and minocycline-ROM) in PB leprosy patients with 2 to 5 skin lesions, India: randomised double-blind trial.
    Manickam P; Nagaraju B; Selvaraj V; Balasubramanyam S; Mahalingam VN; Mehendale SM; Pannikar VK; Gupte MD;
    Indian J Lepr; 2012; 84(3):195-207. PubMed ID: 23484334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 or 3 skin lesions: comparison between ROM and PB-MDT regimens.
    Emmanuel M; Gupte MD
    Indian J Lepr; 2005; 77(1):19-25. PubMed ID: 16173416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy.
    Balagon MF; Cellona RV; Abalos RM; Gelber RH; Saunderson PR
    Lepr Rev; 2010 Mar; 81(1):27-33. PubMed ID: 20496567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
    Kumar A; Girdhar A; Girdhar BK
    Indian J Dermatol Venereol Leprol; 2015; 81(4):356-62. PubMed ID: 26144850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study.
    Martelli CM; Stefani MM; Gomes MK; Rebello PF; Peninni S; Narahashi K; Maroclo AL; Costa MB; Silva SA; Sacchetim SC; Nery JA; Salles AM; Gillis TP; Krahenbuhl JL; Andrade AL
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):247-57. PubMed ID: 11221086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Kars HK
    Indian J Lepr; 1998; 70(2):214-5; author reply 219-21. PubMed ID: 9724859
    [No Abstract]   [Full Text] [Related]  

  • 12. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin.
    Katoch K; Katoch VM; Natarajan M; Gupta UD; Sharma VD; Singh HB
    Indian J Lepr; 2008; 80(4):331-44. PubMed ID: 20329382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Prasad KN
    Indian J Lepr; 1998; 70(2):215-6; author reply 219-21. PubMed ID: 9724860
    [No Abstract]   [Full Text] [Related]  

  • 14. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
    Villahermosa LG; Fajardo TT; Abalos RM; Cellona RV; Balagon MV; Dela Cruz EC; Tan EV; Walsh GP; Walsh DS
    Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Porichha D
    Indian J Lepr; 1998; 70(2):213-4; author reply 219-21. PubMed ID: 9724858
    [No Abstract]   [Full Text] [Related]  

  • 16. Distinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study.
    Costa MB; Cavalcanti Neto PF; Martelli CM; Stefani MM; Maceira JP; Gomes MK; Schettini AP; Rebello PF; Pignataro PE; Ueda ES; Narahashi K; Scollard DM
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):177-86. PubMed ID: 11875761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose ROM therapy in Goa.
    Shukla P; Miranda MS; Prabhudesai R; Rege VL
    Indian J Lepr; 2002; 74(2):169-72. PubMed ID: 12708738
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
    Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
    J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV; Bulchand HO; Revankar CR; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract]   [Full Text] [Related]  

  • 20. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R; Revankar CR; Pai VV; Kingsley S
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.